Explore 3 Stock Ideas & Industry Insights Download Free Report

Relevium Technologies Inc

Healthcare CA RLV

NoneCAD
0.00(0%)

Last update at 2024-02-03T11:36:17.266479Z

Day Range

--
LowHigh

52 Week Range

0.0240.00
LowHigh

Fundamentals

  • Previous Close 37.00
  • Market Cap6.66M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA1.02M
  • Revenue TTM14.25M
  • Revenue Per Share TTM0.05
  • Gross Profit TTM 0.31M
  • Diluted EPS TTM-0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Type yearly yearly yearly yearly yearly
Date 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Income before tax -5.36834M -6.93163M -3.72694M -2.89274M -2.58474M
Minority interest - - - - -
Net income -5.36834M -6.93163M -3.72694M -2.89274M -2.58474M
Selling general administrative 1.89M 3.96M 5.30M 4.28M 1.73M
Selling and marketing expenses - - - - -
Gross profit 0.41M 1.19M 2.19M 2.28M 0.00000M
Reconciled depreciation 0.00466M 0.00466M 0.15M 0.15M 0.07M
Ebit - -2.92450M -3.25793M -2.00690M -1.80096M
Ebitda -4.61280M -6.36029M -3.17870M -1.94525M -2.47813M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -1.47546M -2.77175M -3.25793M -2.14518M -1.80096M
Other operating expenses - - - - 0.06M
Interest expense 0.75M 0.57M 0.40M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - 0.00003M
Net interest income -0.75088M -0.56668M -0.45851M -0.85808M -0.03426M
Extraordinary items - - - - -
Non recurring - - - - 0.58M
Other items - - - - -
Income tax expense - - - 0.00000M 0.00000M
Total revenue 0.91M 2.97M 4.05M 4.15M 0.00000M
Total operating expenses 2.39M 5.75M 7.31M 6.30M 1.80M
Cost of revenue 0.50M 1.78M 1.86M 1.87M 0.00000M
Total other income expense net -3.14200M -3.59320M -0.01049M 0.11M -0.74952M
Discontinued operations - - - - -
Net income from continuing ops -5.36834M -6.93163M -3.72694M -2.89274M -2.58474M
Net income applicable to common shares - -6.93163M -3.72694M -2.89274M -2.58474M
Preferred stock and other adjustments - - - - -
Breakdown 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Type yearly yearly yearly yearly yearly
Date 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Total assets 0.76M 4.33M 8.56M 8.58M 7.12M
Intangible assets 0.57M 3.32M 4.47M 3.46M 0.00000M
Earning assets - - - - -
Other current assets - - 0.07M - 0.00000M
Total liab 5.66M 4.07M 3.51M 3.47M 4.79M
Total stockholder equity -4.90396M 0.27M 5.05M 5.11M 2.32M
Deferred long term liab - - - - -
Other current liab - 0.24M - 0.15M 0.65M
Common stock - 14.07M 13.37M 10.74M 5.18M
Capital stock 14.18M 14.07M 13.37M - -
Retained earnings -23.81967M -18.45133M -11.51971M -7.68529M -4.79254M
Other liab - 0.08M 0.20M 0.11M -
Good will 0.00000M 0.21M 2.28M 2.28M -
Other assets - - - - 6.08M
Cash 0.06M 0.19M 0.88M 2.08M 0.90M
Cash and equivalents - - - - -
Total current liabilities 5.61M 4.20M 1.34M 3.36M 1.29M
Current deferred revenue - - - - -
Net debt 3.13M 2.62M 1.87M 0.79M -
Short term debt - - 0.77M 2.86M 0.03M
Short long term debt 3.20M 2.81M 0.77M 2.86M 0.03M
Short long term debt total - - - - -
Other stockholder equity - 3.02M 1.78M 0.76M 1.70M
Property plant equipment - 0.00985M 0.01M 0.02M -
Total current assets 0.18M 0.79M 1.80M 2.83M 1.04M
Long term investments - - - - -
Net tangible assets - -3.47709M -1.70162M -0.62474M 2.32M
Short term investments 0.00500M 0.00500M 0.00500M 0.00500M 0.00500M
Net receivables 0.17M 0.38M 0.16M 0.14M 0.12M
Long term debt - - 1.97M - 3.50M
Inventory 0.04M 0.13M 0.56M 0.35M 0.00000M
Accounts payable - 1.39M 0.57M 0.35M 0.61M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - 6.76M 5.75M 6.08M
Deferred long term asset charges - - - - -
Non current assets total 0.58M 3.54M 6.76M 5.75M 6.08M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Type yearly yearly yearly yearly yearly
Date 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Investments 0.00000M -0.27660M -0.35115M -0.30847M -2.56348M
Change to liabilities - 0.82M 0.22M -0.26259M 0.21M
Total cashflows from investing activities - -0.27660M -0.35115M -0.30847M -2.53910M
Net borrowings - -0.15671M 1.01M 1.34M 2.10M
Total cash from financing activities -0.00303M 1.76M 2.36M 3.84M 4.69M
Change to operating activities - 0.04M 0.13M -0.24533M 0.02M
Net income -5.36834M -6.93163M -3.72694M -2.89274M -2.58474M
Change in cash -0.13057M -0.68008M -1.20005M 1.17M 0.86M
Begin period cash flow 0.19M 0.88M 2.08M 0.90M 0.05M
End period cash flow 0.06M 0.19M 0.88M 2.08M 0.90M
Total cash from operating activities -0.12754M -2.16252M -3.21213M -2.36086M -1.28902M
Issuance of capital stock 0.09M 0.40M 1.18M - -
Depreciation 0.00466M 0.00466M 0.15M 0.15M 0.07M
Other cashflows from investing activities - -0.27240M -0.07240M -0.07240M -0.07240M
Dividends paid - - - - -
Change to inventory 0.09M 0.43M -0.21584M -0.14716M 0.02M
Change to account receivables - -0.37034M -0.02072M -0.02440M -0.03415M
Sale purchase of stock - - - - 1.50M
Other cashflows from financing activities - 1.45M 0.36M 0.36M 1.09M
Change to netincome - 3.85M 0.19M 1.01M 1.01M
Capital expenditures 0.00000M 0.00420M 0.00211M 0.02M 0.02M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.51M 0.92M 0.12M -0.67948M 0.22M
Stock based compensation 0.05M 0.03M 0.03M - -
Other non cash items 0.69M 0.57M 0.15M 0.36M 0.22M
Free cash flow -0.12754M -2.16672M -3.41975M -2.44513M -1.28905M

Peer Comparison

Sector: Healthcare Industry: Pharmaceutical Retailers

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
RLV
Relevium Technologies Inc
- -% - - - 6.64 200.06 9.08 -1.419
HITI
High Tide Inc
-0.08 2.41% 3.24 - 45.05 0.46 3.36 0.65 10.91
PCRX
PharmaCorp Rx Inc.
- -% 0.51 20.50 41.49 2.78 1.65 2.77 41.56

Reports Covered

Stock Research & News

Profile

Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.

Relevium Technologies Inc

1000 Sherbrooke Street West, Montreal, QC, Canada, H3A 3G4

Key Executives

Name Title Year Born
Mr. Aurelio Useche C.M.A., M.B.A. Pres, CEO & Director 1968
Mr. Mark Anthony Billings C.F.A., CFA, M.B.A., MBA Chief Financial Officer 1970
Mr. Edward Ierfino B. Comm. Mang. of Investor Relations 1968
Mr. Abis Hussain Sr. Marketing Officer NA
Mr. David A. Johnson Corp. Sec. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions